Laser treatment for retinopathy of prematurity

Lasers in Medical Science

Volumn 28, Issue 2, 2013, Pages 683-692

  Houston, Samuel K ^a   Wykoff, Charles C ^a   Berrocal, Audina M ^a   Hess, Ditte J ^a   Murray, Timothy G ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenesis; Hypoxia; Laser photocoagulation; Retina; Retinopathy of prematurity

Indexed keywords

BEVACIZUMAB; OMEGA 3 FATTY ACID; OXYGEN; PEGAPTANIB; RANIBIZUMAB; VASCULOTROPIN INHIBITOR;

ANTERIOR EYE SEGMENT; BURN; CATARACT; CHOROID HEMORRHAGE; CLINICAL OBSERVATION; CORNEA OPACITY; CRYOTHERAPY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; HUMAN; INCIDENCE; INTRAOCULAR HEMORRHAGE; INTRAOCULAR HYPOTENSION; LASER COAGULATION; LASER SURGERY; LOW LEVEL LASER THERAPY; LUNG TUBERCULOSIS; MYOPIA; NONHUMAN; OFF LABEL DRUG USE; OPHTHALMOSCOPY; OXYGEN THERAPY; PATHOGENESIS; PRIORITY JOURNAL; RETINA TEAR; RETINOPATHY; RETROLENTAL FIBROPLASIA; REVIEW; RISK FACTOR; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SYSTEMIC DISEASE; TELEMEDICINE; THERAPY EFFECT; TREATMENT OUTCOME; VITREOUS HEMORRHAGE;

HUMANS; INFANT, NEWBORN; LASER COAGULATION; RETINOPATHY OF PREMATURITY;

EID: 84879684573     PISSN: 02688921     EISSN: 1435604X     Source Type: Journal    
DOI: 10.1007/s10103-011-1021-z     Document Type: Review

References (60)

1. Terry TL (1944) Retrolental fibroplasia in the premature infant: v. further studies on fibroplastic overgrowth of the persistent tunica vasculosa lentis. Trans Am Ophthalmol Soc 42:383-396
2. Goldberg MF (1997) Persistent fetal vasculature (PFV): an integrated interpretation of signs and symptoms associated with persistent hyperplastic primary vitreous (PHPV). LIV Edward Jackson Memorial Lecture. Am J Ophthalmol 124(5):587-626
3. Michaelson IC (1948) Vascular morphogenesis in the retina of the cat. J Anat 82(3):167-174, 4
4. Ashton N, Cook C (1954) Direct observation of the effect of oxygen on developing vessels: preliminary report. Br J Ophthalmol 38(7):433-440
5. Xu Q et al (2004) Vascular development in the retina and inner ear: control by Norrin and Frizzled-4, a high-affinity ligand-receptor pair. Cell 116(6):883-895
6. Hughes S, Yang H, Chan-Ling T (2000) Vascularization of the human fetal retina: roles of vasculogenesis and angiogenesis. Invest Ophthalmol Vis Sci 41(5):1217-1228
7. Chan-Ling T et al (2004) Desmin ensheathment ratio as an indicator of vessel stability: evidence in normal development and in retinopathy of prematurity. Am J Pathol 165(4):1301-1313
8. Chan-Ling T, Gock B, Stone J (1995) The effect of oxygen on vasoformative cell division. evidence that 'physiological hypoxia' is the stimulus for normal retinal vasculogenesis. Invest Ophthalmol Vis Sci 36(7):1201-1214
9. Shweiki D et al (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359(6398):843-845
10. Smith LE (2008) Through the eyes of a child: understanding retinopathy through ROP (The Friedenwald lecture). Invest Ophthalmol Vis Sci 49(12):5177-5182
11. Hellstrom A et al (2001) Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity. Proc Natl Acad Sci USA 98(10):5804-5808
12. Heidary G, Vanderveen D, Smith LE (2009) Retinopathy of prematurity: current concepts in molecular pathogenesis. Semin Ophthalmol 24(2):77-81
13. Terry TL (1942) Fibroblastic overgrowth of persistent tunica vasculosa lentis in infants born prematurely: ii. report of cases-clinical aspects. Trans Am Ophthalmol Soc 40:262-284
14. Tasman W et al (2006) Retinopathy of prematurity: the life of a lifetime disease. Am J Ophthalmol 141(1):167-174
15. Ashton N, Ward B, Serpell G (1953) Role of oxygen in the genesis of retrolental fibroplasia; a preliminary report. Br J Ophthalmol 37(9):513-520
16. Ashton N (1954) Pathological basis of retrolental fibroplasia. Br J Ophthalmol 38(7):385-396
17. Palmer EA et al (2005) 15-year outcomes following threshold retinopathy of prematurity: final results from the multicenter trial of cryotherapy for retinopathy of prematurity. Arch Ophthalmol 123(3):311-318
18. Cryotherapy for Retinopathy of Prematurity Cooperative Group (1988) Multicenter trial of cryotherapy for retinopathy of prematurity. preliminary results. Arch Ophthalmol 106(4):471-479
19. Good WV (2004) Final results of the early treatment for retinopathy of prematurity (ETROP) randomized trial. Trans Am Ophthalmol Soc 102:233-248, Discussion 248-50
20. (2000) Supplemental Therapeutic Oxygen for Pre threshold Retinopathy Of Prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes. Pediatrics 105(2):295-310
21. Askie LM, Henderson-Smart DJ, Ko H (2009) Restricted versus liberal oxygen exposure for preventing morbidity and mortality in preterm or low birth weight infants. Cochrane Database Syst Rev (1):CD001077
22. Section on Ophthalmology American Academy of Pediatrics; American Academy of Ophthalmology; American Association for Pediatric Ophthalmology and Strabismus (2006) Screening examination of premature infants for retinopathy of prematurity. Pediatrics 117(2):572-576
23. Clark D, Mandal K (2008) Treatment of retinopathy of prematurity. Early Hum Dev 84(2):95-99
24. International Committee for the Classification of Retinopathy of Prematurity (2005) The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol 123(7):991-999
25. Chiang MF et al (2007) Interexpert agreement of plus disease diagnosis in retinopathy of prematurity. Arch Ophthalmol 125(7):875-880
26. Lorenz B et al (2009) Wide-field digital imaging based telemedicine for screening for acute retinopathy of prematurity (ROP). Six-year results of a multicentre field study. Graefes Arch Clin Exp Ophthalmol 247(9):1251-1262
27. Ells AL et al (2003) Telemedicine approach to screening for severe retinopathy of prematurity: a pilot study. Ophthalmology 110(11):2113-2117
28. Schwartz SD et al (2000) Telemedical evaluation and management of retinopathy of prematurity using a fiberoptic digital fundus camera. Ophthalmology 107(1):25-28
29. Wallace DK, Freedman SF, Zhao Z (2009) A pilot study using ROPtool to measure retinal vascular dilation. Retina 29(8):1182-1187
30. Murakami Y et al (2010) Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP): 24-month experience with telemedicine screening. Acta Ophthalmol 88(3):317-322
31. Seiberth V et al (1995) Diode laser photocoagulation for stage 3+ retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol 233(8):489-493
32. McNamara JA et al (1992) Diode laser photocoagulation for retinopathy of prematurity. preliminary results. Arch Ophthalmol 110(12):1714-1716
33. Banach MJ, Ferrone PJ, Trese MT (2000) A comparison of dense versus less dense diode laser photocoagulation patterns for threshold retinopathy of prematurity. Ophthalmology 107(2):324-327, discussion 328
34. Tsitsis T et al (1997) Diode laser photocoagulation for retinopathy of prematurity. Trans Am Ophthalmol Soc 95:231-236, discussion 237-45
35. Shalev B, Farr AK, Repka MX (2001) Randomized comparison of diode laser photocoagulation versus cryotherapy for threshold retinopathy of prematurity: seven-year outcome. Am J Ophthalmol 132(1):76-80
36. Cryotherapy for Retinopathy of Prematurity Cooperative Group (2002) Multicenter trial of cryotherapy for retinopathy of prematurity: natural history ROP: ocular outcome at 5(1/2) years in premature infants with birth weights less than 1251 g. Arch Ophthalmol 120(5):595-599
37. Connolly BP et al (2002) A comparison of laser photocoagulation with cryotherapy for threshold retinopathy of prematurity at 10 years: part 2. Refractive outcome. Ophthalmology 109(5):936-941
38. Ng EY et al (2002) A comparison of laser photocoagulation with cryotherapy for threshold retinopathy of prematurity at 10 years: part 1. Visual function and structural outcome. Ophthalmology 109(5):928-934, discussion 935
39. Early Treatment For Retinopathy Of Prematurity Cooperative (2003) Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol 121(12):1684-1694
40. Good WV et al (2010) Final visual acuity results in the early treatment for retinopathy of prematurity study. Arch Ophthalmol 128(6):663-671
41. McNamara JA (1993) Laser treatment for retinopathy of prematurity. Curr Opin Ophthalmol 4(3):76-80
42. Banach MJ, Berinstein DM (2001) Laser therapy for retinopathy of prematurity. Curr Opin Ophthalmol 12(3):164-170
43. Rezai KA et al (2005) Near confluent laser photocoagulation for the treatment of threshold retinopathy of prematurity. Arch Ophthalmol 123(5):621-626
44. Prenner JL, Capone A Jr, Trese MT (2004) Visual outcomes after lens-sparing vitrectomy for stage 4A retinopathy of prematurity. Ophthalmology 111(12):2271-2273
45. Kaiser RS, Trese MT (2001) Iris atrophy, cataracts, and hypotony following peripheral ablation for threshold retinopathy of prematurity. Arch Ophthalmol 119(4):615-617
46. Lambert SR et al (2000) Cataract and phthisis bulbi after laser photoablation for threshold retinopathy of prematurity. Am J Ophthalmol 129(5):585-591
47. Simons BD et al (1998) Bilateral hyphemas and cataracts after diode laser retinal photoablation for retinopathy of prematurity. J Pediatr Ophthalmol Strabismus 35(3):185-187
48. Gaitan JR et al (2008) Anterior segment ischemia following laser therapy for threshold retinopathy of prematurity. Retina 28(3):55-57
49. Christiansen SP, Bradford JD (1995) Cataract in infants treated with argon laser photocoagulation for threshold retinopathy of prematurity. Am J Ophthalmol 119(2):175-180
50. Drack AV et al (1992) Transient punctate lenticular opacities as a complication of argon laser photoablation in an infant with retinopathy of prematurity. Am J Ophthalmol 113(5):583-584
51. Kent D et al (2000) The influence of retinopathy of prematurity on ocular growth. Eye (Lond) 14(1):23-29
52. Lalwani GA et al (2008) Off-label use of intravitreal bevacizumab (Avastin) for salvage treatment in progressive threshold retinopathy of prematurity. Retina 28(3):13-18
53. Mintz-Hittner HA, Kuffel RR Jr (2008) Intravitreal injection of bevacizumab (Avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II. Retina 28(6):831-838
54. Kusaka S et al (2008) Efficacy of intravitreal injection of bevacizumab for severe retinopathy of prematurity: a pilot study. Br J Ophthalmol 92(11):1450-1455
55. Quiroz-Mercado H et al (2008) Antiangiogenic therapy with intravitreal bevacizumab for retinopathy of prematurity. Retina 28(3):19-25
56. Wu WC et al (2011) Effects and complications of bevacizumab use in patients with retinopathy of prematurity: a multicenter study in Taiwan. Ophthalmology 118(1):176-183
57. Mintz-Hittner HA, Kennedy KA, Chuang AZ (2011) Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med 364(7):603-615
58. Shah N et al (2010) The effect of recombinant human erythropoietin on the development of retinopathy of prematurity. Am J Perinatol 27(1):67-71
59. Connor KM et al (2007) Increased dietary intake of omega-3- polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nat Med 13(7):868-873
60. Mantagos IS, Vanderveen DK, Smith LE (2009) Emerging treatments for retinopathy of prematurity. Semin Ophthalmol 24(2):82-86